TSRC Corporation (2103.TW)
Kaohsiung, TW
TSRC Corporation, established in Kaohsiung, Taiwan, in 1973, operates internationally as a manufacturer, importer, and distributor of various synthetic rubber products and related materials. Its global footprint spans Taiwan, other parts of Asia, North America, and Europe. The company's product portfolio encompasses several types of rubber, each tailored for specific applications: ESBR rubber is extensively used in automotive tires, shoe outsoles, conveyor systems, military tracks (for caterpillars and tow trucks), sporting goods, and toys. SSBR rubber is formulated for modern tires, including energy-saving, high-performance, and all-season variants. BR rubber serves to modify plastics, particularly High Impact Polystyrene (HIPS), and is a component in high-speed radial tires. NBR rubber is critical for industrial applications such as oil hoses and seals, rollers, industrial gaskets, belts, shoe soles, rubber-plastic foam sheets, and conveyor belts. Furthermore, TSRC offers various copolymers, including styrene-butadiene-styrene, styrene-isoprene-styrene, and styrene-ethylene/butylene-styrene. Its T-BLEND applied materials are utilized in advanced footwear components, foam production, soft-touch and gel products, and overmolding processes. The company was formerly known as Taiwan Synthetic Rubber Corporation until it rebranded as TSRC Corporation in August 1999.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.95% | +6.77% | +8.95% | +19.33% | +44.90% | +37.42% | +8.67% | -19.01% | -35.36% | -22.55% | +192.18% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-02 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-2.0% Q1'26: -0.4% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-48.1% Q1'26: +32.5% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+0.1% Q1'26: +0.3% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+2.3% Q1'26: +6.3% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+1.8% Q1'26: +5.6% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+36.0% Q1'26: +14.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×6.66× Q1'26: 5.12× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
25.98B
est: 25.99B (0.0%)
|
26.96B
est: 27.06B (-0.4%)
|
31.77B
est: 33.11B (-4.1%)
|
29.75B
est: 30.29B (-1.8%)
|
28.91B
est: 30.58B (-5.5%)
|
24.02B
est: 25.49B (-5.7%)
|
32.53B
est: 32.81B (-0.9%)
|
33.84B
est: 34.55B (-2.0%)
|
31.43B
est: 32.06B (-2.0%)
|
37.21B
est: 37.04B (+0.4%)
|
36.47B
est: 32.99B (+10.6%)
|
32.99B
32.99B – 32.99B
+0.0% YoY
|
| EBITDA |
1.90B
est: 2.78B (-31.6%)
|
2.92B
est: 2.89B (+1.0%)
|
2.49B
est: 3.54B (-29.6%)
|
2.83B
est: 3.23B (-12.6%)
|
2.40B
est: 3.27B (-26.6%)
|
1.48B
est: 2.72B (-45.5%)
|
6.14B
est: 3.50B (+75.2%)
|
4.23B
est: 3.69B (+14.6%)
|
2.67B
est: 3.38B (-21.0%)
|
2.74B
est: 3.90B (-29.8%)
|
2.00B
est: 3.48B (-42.4%)
|
3.48B
3.48B – 3.48B
+0.0% YoY
|
| EBIT |
802.10M
est: 1.75B (-54.2%)
|
1.85B
est: 1.82B (+1.3%)
|
1.49B
est: 2.23B (-33.5%)
|
1.80B
est: 2.04B (-11.9%)
|
1.26B
est: 2.06B (-39.0%)
|
342.73M
est: 1.72B (-80.1%)
|
4.94B
est: 2.21B (+123.3%)
|
2.93B
est: 2.33B (+25.9%)
|
1.35B
est: 2.22B (-39.0%)
|
1.54B
est: 2.56B (-39.9%)
|
824.47M
est: 2.28B (-63.8%)
|
2.28B
2.28B – 2.28B
+0.0% YoY
|
| Net Income |
529.12M
est: 663.11M (-20.2%)
|
988.35M
est: 1.19B (-17.0%)
|
874.11M
est: 868.54M (+0.6%)
|
1.19B
est: 1.06B (+12.0%)
|
740.32M
est: 905.85M (-18.3%)
|
215.26M
est: 80.15M (+168.6%)
|
3.93B
est: 4.11B (-4.3%)
|
1.78B
est: 2.15B (-17.2%)
|
680.02M
est: 935.56M (-27.3%)
|
862.27M
est: 1.40B (-38.5%)
|
448.46M
est: 1.38B (-67.4%)
|
947.00M
947.00M – 947.00M
-31.1% YoY
|
| SGA |
1.81B
est: 1.99B (-9.1%)
|
1.90B
est: 2.07B (-8.4%)
|
1.97B
est: 2.54B (-22.4%)
|
2.04B
est: 2.32B (-12.1%)
|
2.07B
est: 2.35B (-11.7%)
|
1.95B
est: 1.95B (-0.2%)
|
2.77B
est: 2.52B (+10.1%)
|
2.72B
est: 2.65B (+2.7%)
|
2.19B
est: 2.35B (-6.6%)
|
2.49B
est: 2.72B (-8.5%)
|
2.35B
est: 2.42B (-3.0%)
|
2.42B
2.42B – 2.42B
+0.0% YoY
|
| EPS |
0.64
est: 0.80 (-20.0%)
|
1.20
est: 1.44 (-16.5%)
|
1.06
est: 1.05 (+1.2%)
|
1.44
est: 1.28 (+12.2%)
|
0.90
est: 1.09 (-17.6%)
|
0.26
est: 0.10 (+169.0%)
|
4.76
est: 4.95 (-3.9%)
|
2.16
est: 2.60 (-16.8%)
|
0.82
est: 0.83 (-1.2%)
|
1.04
est: 1.24 (-16.4%)
|
0.54
est: 1.22 (-55.7%)
|
0.84
0.84 – 0.84
-31.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-05 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-04 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Emerging Markets SmallCap Dividend UCITS ETF DGSD.L | 0.05% | 21.6K | 0.54% |
| 2 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.04% | 42.6K | 0.42% |
| 3 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.03% | 228.2K | 0.65% |
| 4 | Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L | 0.01% | 27.2K | 0.35% |
| 5 | Dimensional - Emerging Markets Value ETF DFEV | 0.01% | 189.8K | 0.46% |
| 6 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 1.18M | 0.06% |
| 7 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.01% | 22.5K | 0.56% |
| 8 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.01% | 35.5K | 0.44% |
| 9 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 399.3K | 0.39% |
| 10 | Avantis Responsible Emerging Markets Equity ETF AVSE | 0.00% | 9.4K | 0.33% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chi-Wei Hsu | Vice President of Operations Division & Global Head of Operations | — | male |
| Edward Wang | Vice President of Finance & Advanced Materials Division | — | male |
| Iting Tsai | Senior Assistant Vice President of Legal Department | — | male |
| Maggie Huang | Assistance Vice President of Human Resources & Management Department | — | female |
| Weiqiang Chai | Chief Executive Officer & Manager | — | male |
| Xing Rong Lin | Accounting Supervisor | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 2103.TW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
